Clinical Trials Directory

Trials / Completed

CompletedNCT03535077

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Assessing Tissue Remodeling in the Skin Using Skin Fluorescence Imaging (SFI)

Status
Completed
Phase
Study type
Observational
Enrollment
186 (actual)
Sponsor
Orlucent, Inc · Industry
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin

Detailed description

The goal of the SFI is to provide non-invasive information about tissue remodeling occurring during melanocytic transition and atypia development in the skin. SFI analyzes the topical staining of the skin surface using the ORL-1 dye to reveal the presence of remodeling in the skin, together with the visible feature characteristics. The system provides a biometric score corresponding to the dye staining, a structural score, and a composite SFI score to quantify the presence of tissue remodeling and the process of melanocytic transition in the skin.

Conditions

Interventions

TypeNameDescription
OTHERDiagnostic TestImaging of the suspicious lesion after application of ORL-1 dye prior to biopsy

Timeline

Start date
2018-01-24
Primary completion
2022-12-31
Completion
2022-12-31
First posted
2018-05-24
Last updated
2024-01-10

Locations

6 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT03535077. Inclusion in this directory is not an endorsement.